• GSK J4 HCl for JMJD3 and CXCL10 Assays

  2026-09-26

  Use GSK J4 HCl to test whether JMJD3-dependent H3K27 demethylation contributes to chemokine regulation in decidual-cell models—not as a substitute for testing the hCG–EZH2 pathway directly. This guide connects the reference study to a practical dose-response, chromatin, and chemotaxis workflow, with controls to separate target-level effects from cell stress.

• Belinostat (PXD101): Workflows for HDAC Research

  2026-09-25

  Belinostat (PXD101) provides a practical tool for testing histone deacetylase inhibition, histone acetylation, and growth responses in cancer cell models. This guide separates established bladder and prostate benchmarks from a carefully controlled, hypothesis-testing workflow for studying HDAC inhibition alongside spliceosome and PARP-inhibitor biology in hepatocellular carcinoma.

• Apicidin Disrupts Oocyte Maturation and Epigenetic Control

  2026-09-25

  A 2026 in vitro oocyte study reports that Apicidin delays meiotic maturation while disrupting spindle and chromosome organization, reducing actin filament density, and changing histone and tubulin acetylation. The findings connect a food- and feed-associated mycotoxin with measurable defects in germ-cell quality, while leaving dose relevance and the causal role of HDAC changes open for further study.

• Berberrubine and Metabolic Recovery in Fatty Liver Disease

  2026-09-24

  A 2022 study tested berberrubine, a major berberine metabolite, in high-fat-diet mice and oleic-acid-treated HepG2 cells, reporting improvements in hepatic steatosis and insulin resistance alongside changes in metabolic proteins and gut microbiota. The findings support berberrubine as a candidate for further mechanistic and translational study, while leaving human efficacy and microbiome causality unresolved.

• NADH Redox Control in Fungal Metabolism

  2026-09-24

  NADH is more than an electron carrier: its balance with NAD⁺ can shape how filamentous fungi adapt to oxygen limitation and produce metabolites. This article translates a fungal redox-homeostasis review into practical assay decisions while clarifying what its findings do—and do not—imply for other NADH research.

• SmD2 Acetylation Links HCC Splicing to PARP Sensitivity

  2026-09-23

  This study identifies an acetylation-controlled role for the spliceosome protein SmD2 in hepatocellular carcinoma (HCC): HDAC2-mediated deacetylation stabilizes SmD2, which influences BRCA1/FANC cassette-exon processing and DNA-damage repair. Disrupting this pathway, including with Romidepsin alongside the PARP inhibitor olaparib, sensitized HCC models to PARP inhibition and suggests a preclinical strategy for tumors without established BRCA deficiency.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-09-23

  This study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette-exon processing, and DNA-damage repair in hepatocellular carcinoma. Its findings support combining HDAC2-directed intervention with PARP inhibition to increase treatment sensitivity in HCC models.

• Cholesterol: From Membrane Variable to Assay Insight

  2026-09-22

  Cholesterol is the principal sterol for interpreting membrane behavior, lipid metabolism research, and delivery-associated cell responses. This article presents a causal assay framework that distinguishes direct cholesterol effects from lipid nanoparticle and p21 mRNA biology.

• AMC-Hem Illuminates Real-Time HO-1 Regulation

  2026-09-22

  The reference study introduces AMC-Hem, a red-shifted aminocoumarin–heme fluorescent probe designed to report heme oxygenase-1 activity rather than simply protein abundance. In live human macrophages and serum, the probe revealed compartmentalized HO-1 activity, non-transcriptional regulation by small molecules, and a practical route toward dynamic biochemical measurements.

• DiscoveryProbe Metabolism Library: Assay Logic

  2026-09-21

  The DiscoveryProbe Metabolism-related Compound Library supports mechanism-led metabolic screening rather than simple compound enumeration. This article shows how its chemical diversity can be mapped onto redox, lipid, and PPAR signaling assays using insights from a cardiac ANP study.

• GSK343: Reframing EZH2 Inhibition for Translation

  2026-09-21

  GSK343 offers a precise way to interrogate EZH2-dependent chromatin repression while keeping translational conclusions appropriately bounded. By connecting PRC2 biology with emerging evidence that APEX2 supports TERT expression through DNA repair at repetitive regions, this article outlines a practical strategy for moving from target engagement to mechanistic insight in epigenetic cancer research.

• Valemetostat (DS-3201) Research Workflow

  2026-09-20

  Build a translational Valemetostat workflow that connects EZH2 genotype, PRC2 target engagement, and lymphoma-cell response. The guide separates evidence from optimization advice, helping researchers use this selective epigenetic probe in EZH2 mutant inhibition, follicular lymphoma, and broader lymphoma studies.

• Primidone: From Target Assays to Translational Design

  2026-09-19

  Primidone and Mysoline are more than established neurological medicines: they are useful probes for TRPM3, RIPK1, and selected enzyme assays. This evidence-led guide shows how to connect biochemical potency, assay architecture, model dosing, and translational interpretation without confusing mechanistic plausibility with therapeutic proof.

• Toremifene in Breast Cancer: 20-Year Evidence Review

  2026-09-18

  This review examines how two decades of clinical and translational evidence position toremifene as an oral selective estrogen receptor modulator for hormone receptor–positive breast cancer. Its main contribution is a clinically focused synthesis showing broadly comparable efficacy with tamoxifen, no confirmed overall safety advantage, and a distinct pharmacokinetic profile that may inform treatment selection in selected postmenopausal patients.

• From Reporter Signal to Translational mRNA Insight

  2026-09-18

  A mechanistic and strategic guide to using EZ Cap™ Firefly Luciferase mRNA as a calibrated reporter for mRNA delivery, translation, gene regulation, and in vivo imaging—while accounting for formulation, route, inflammation, and biological context.

8726 records 5/582 page Previous Next 12345 下5页 Last page